Beijing Tong Ren Tang Chinese Medicine Company Limited - Laporan Laba Rugi (TTM)

Beijing Tong Ren Tang Chinese Medicine Company Limited
DE ˙ DB ˙ HK0000145638
€ 0.97 ↑0.02 (1.57%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Beijing Tong Ren Tang Chinese Medicine Company Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,246 1,315 1,384 1,452 1,504 1,556 1,517 1,478 1,605 1,731 1,824 1,918 1,721 1,525 1,451 1,377 1,494 1,612 1,660 1,709
Change (%) 5.53 5.19 4.94 3.59 3.46 -2.50 -2.56 8.54 7.87 5.39 5.11 -10.24 -11.40 -4.86 -5.11 8.53 7.86 3.02 2.93
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 369 362 375 388 412 437 432 427 504 581 637 693 585 478 431 385 466 546 589 632
Change (%) -1.84 3.56 3.44 6.22 5.85 -1.15 -1.16 18.11 15.33 9.63 8.79 -15.53 -18.38 -9.74 -10.79 21.01 17.36 7.87 7.29
% of Revenue 29.62 27.55 27.13 26.74 27.42 28.05 28.44 28.85 31.39 33.56 34.91 36.13 34.00 31.33 29.72 27.94 31.16 33.90 35.49 37.00
Gross Operating Profit 877 953 1,008 1,064 1,092 1,120 1,086 1,052 1,101 1,150 1,187 1,225 1,136 1,047 1,020 992 1,029 1,065 1,071 1,077
Change (%) 8.63 5.81 5.49 2.63 2.56 -3.02 -3.12 4.67 4.46 3.24 3.14 -7.24 -7.81 -2.64 -2.71 3.70 3.57 0.53 0.53
% of Revenue 70.38 72.45 72.87 73.26 72.58 71.95 71.56 71.15 68.61 66.44 65.09 63.87 66.00 68.67 70.28 72.06 68.84 66.10 64.51 63.00
SG&A 314 311 324 337 343 349 343 337 343 348 366 384 408 431 440 448 471 494 495 496
Change (%) -0.90 4.13 3.97 1.83 1.80 -1.71 -1.74 1.62 1.60 5.15 4.90 6.18 5.82 1.95 1.91 5.09 4.84 0.19 0.19
% of Revenue 25.19 23.65 23.42 23.20 22.81 22.44 22.62 22.81 21.35 20.11 20.07 20.03 23.69 28.29 30.32 32.57 31.53 30.65 29.81 29.01
R&D
Change (%)
% of Revenue
OpEx 677 672 700 728 756 784 773 762 844 927 1,001 1,075 988 901 862 824 931 1,038 1,083 1,128
Change (%) -0.78 4.21 4.04 3.84 3.69 -1.42 -1.44 10.81 9.76 8.00 7.41 -8.09 -8.80 -4.28 -4.47 12.97 11.48 4.37 4.19
% of Revenue 54.31 51.06 50.59 50.15 50.27 50.38 50.94 51.53 52.61 53.53 54.86 56.06 57.40 59.09 59.45 59.85 62.29 64.38 65.23 66.03
Operating Income 570 644 684 724 748 772 744 717 761 804 824 843 733 624 588 553 563 574 577 581
Change (%) 13.02 6.22 5.86 3.34 3.23 -3.59 -3.73 6.13 5.77 2.37 2.31 -12.98 -14.91 -5.70 -6.05 1.93 1.89 0.56 0.56
% of Revenue 45.69 48.94 49.41 49.85 49.73 49.62 49.06 48.47 47.39 46.47 45.14 43.94 42.60 40.91 40.55 40.15 37.71 35.62 34.77 33.97
Interest Expense -4 -4 -4 -5 -5 -5 -5 -5 -5 -5 -5 -5 -5 -6 -6 -7 -7 -6 -7 -7
Change (%) 2.07 2.86 2.78 1.77 1.74 2.58 2.52 -2.92 -3.01 2.32 2.26 11.29 10.14 4.60 4.40 -0.36 -0.36 1.23 1.22
% of Revenue -0.34 -0.33 -0.32 -0.31 -0.31 -0.30 -0.32 -0.33 -0.30 -0.27 -0.26 -0.25 -0.32 -0.39 -0.43 -0.47 -0.44 -0.40 -0.40 -0.39
Net Income 483 542 563 583 595 608 582 555 601 646 672 697 619 540 517 494 497 500 508 515
Change (%) 12.24 3.75 3.61 2.12 2.08 -4.33 -4.52 8.16 7.54 3.98 3.83 -11.25 -12.68 -4.28 -4.47 0.62 0.62 1.51 1.49
% of Revenue 38.77 41.24 40.67 40.16 39.59 39.06 38.33 37.56 37.42 37.31 36.81 36.36 35.95 35.44 35.65 35.89 33.28 31.04 30.59 30.16

Source: Capital IQ

Other Listings
HK:3613 HK$ 9.03
US:BJTRF
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista